BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3083891)

  • 1. Analysis of natural killer cells in patients with aplastic anemia.
    Gascón P; Zoumbos N; Young N
    Blood; 1986 May; 67(5):1349-55. PubMed ID: 3083891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin.
    Gascon P; Zoumbos NC; Scala G; Djeu JY; Moore JG; Young NS
    Blood; 1985 Feb; 65(2):407-13. PubMed ID: 2981588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High cytotoxic cell activity in the marrow from patients with aplastic anemia.
    Morikawa K; Nakano A; Oseko F; Morikawa S
    Jpn J Med; 1989; 28(5):585-92. PubMed ID: 2585885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilymphocyte globulin therapy enhances impaired function of natural killer cells and lymphokine activated killer cells in aplastic anaemia.
    Myint AA; Malkovska V; Morgan S; Luckit J; Wonke B; Gordon-Smith EC
    Br J Haematol; 1990 Aug; 75(4):578-84. PubMed ID: 2207010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant clonal expansion of large granular lymphocytes with a Leu-11+, Leu-7- surface phenotype: in vitro responsiveness of malignant cells to recombinant human interleukin 2.
    Koizumi S; Seki H; Tachinami T; Taniguchi M; Matsuda A; Taga K; Nakarai T; Kato E; Taniguchi N; Nakamura H
    Blood; 1986 Nov; 68(5):1065-73. PubMed ID: 2945603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating activated suppressor T lymphocytes in aplastic anemia.
    Zoumbos NC; Gascón P; Djeu JY; Trost SR; Young NS
    N Engl J Med; 1985 Jan; 312(5):257-65. PubMed ID: 2981406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia.
    Liu C; Li Z; Sheng W; Fu R; Li L; Zhang T; Wu Y; Xing L; Song J; Wang H; Shao Z
    Immunol Invest; 2014; 43(5):491-503. PubMed ID: 24661133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased interleukin-1 production in aplastic anemia.
    Gascon P; Scala G
    Am J Med; 1988 Nov; 85(5):668-74. PubMed ID: 3263800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of antilymphocyte and antithymocyte globulins for patients with severe aplastic anemia and pure red cell aplasia--analysis of immunologic parameters of peripheral lymphocytes concerning ALG and ATG therapy].
    Kawauchi K; Sugiyama H; Watanabe H; Urabe A; Takaku F
    Rinsho Ketsueki; 1990 Jan; 31(1):10-5. PubMed ID: 2107342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte phenotype and lymphokines following anti-thymocyte globulin therapy in patients with aplastic anaemia.
    Platanias L; Gascon P; Bielory L; Griffith P; Nienhuis A; Young N
    Br J Haematol; 1987 Aug; 66(4):437-43. PubMed ID: 3117088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aplastic anemia associated with bone marrow suppressor T-cell hyperactivity: successful treatment with antithymocyte globulin.
    Amare M; Abdou NL; Robinson MG; Abdou NI
    Am J Hematol; 1978; 5(1):25-32. PubMed ID: 311583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in peripheral blood mononuclear cell subpopulations during antithymocyte globulin therapy for severe aplastic anemia.
    López-Karpovitch X; Zarzosa ME; Cárdenas MR; Piedras J
    Acta Haematol; 1989; 81(4):176-80. PubMed ID: 2502890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective natural killer cell activity of peripheral blood lymphocytes correlates with the degree of neutropenia in patients with chronic idiopathic neutropenia of adults.
    Papadaki HA; Coulocheri S; Xylouri I; Chatzivassili A; Konsolas J; Katrinakis G; Karkavitsas N; Eliopoulos GD
    Ann Hematol; 1998; 76(3-4):127-34. PubMed ID: 9619729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro production of granulocyte-macrophage colony-stimulating factor in aplastic anemia: possible mechanisms of action of antithymocyte globulin.
    Nimer SD; Golde DW; Kwan K; Lee K; Clark S; Champlin R
    Blood; 1991 Jul; 78(1):163-8. PubMed ID: 2070050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [NK and K cell activity in children with leukemias and aplastic anemias before and after allogeneic bone marrow transplantation].
    Thränhardt H; Prager J; Fuchs D; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):285-92. PubMed ID: 2410337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in bone marrow MRI patterns in aplastic anemia before and after successful treatment with ATG].
    Yagisawa M; Iki S; Mitani K; Ohbayashi Y; Sato H; Urabe A
    Rinsho Ketsueki; 1992 Jun; 33(6):811-6. PubMed ID: 1433922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient natural killer (NK) cells in paroxysmal nocturnal haemoglobinuria (PNH): studies of lymphoid cells fractionated by discontinuous density gradient centrifugation.
    Yoda Y; Abe T
    Br J Haematol; 1985 Aug; 60(4):669-75. PubMed ID: 4027193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to glycosylphosphatidyl-inositol anchored proteins (GPI-AP) in antithymocyte and antilymphocyte globulin: possible role for the expansion of GPI-AP deficient cells in aplastic anemia.
    Breitinger HH; Rojewski MT; Schrezenmeier H
    Ann Hematol; 2009 Sep; 88(9):889-95. PubMed ID: 19137453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms accounting for the impaired natural-killer cell activity in refractory anaemia with excess of blasts.
    Eliopoulos GD; Coulocheri SA; Eliopoulos AG; Katrinakis G; Karkavitsas N; Kyriakou D; Vaiopoulos G; Foudoulakis A
    Eur J Haematol; 1992 May; 48(5):237-43. PubMed ID: 1379537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.